Charlotte Harrison
Senior Clinical Research Associate
Data updated
Research Footprint
Charlotte Harrison appears in 4 tracked papers (2021–2024), most studied alongside MDMA and Placebo, across PTSD, Safety & Risk Management and Depressive Disorders.
Most-cited paper: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study (942 citations).
Frequent co-authors: Berra Yazar-Klosinski, Michael Mithoefer and Rick Doblin.
Background & Research
Charlotte Harrison is a Senior Clinical Research Associate at MAPS Public Benefit Corporation, where she has helped support clinical trial operations for MDMA-assisted psychotherapy research. A MAPS profile from 2017 describes her as contributing to the organization’s Phase 3 PTSD studies and having prior experience monitoring multiple clinical trials across therapeutic areas. She is associated with the MDMA-assisted therapy publications you listed, which suggests she has been involved in the research infrastructure supporting these late-stage trials.
Key Impact
She appears as an author on multiple MAPS phase 3 MDMA-assisted therapy papers, indicating a key operational role in the clinical trial program.
Collaboration Network
16 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Charlotte Harrison is associated with.